ICMR-NIIH

आई सी एम आर - राष्ट्रीय प्रतिरक्षा रुधिर विज्ञान संस्थान

ICMR-National Institute of Immunohaematology

NIIH Logo NIIH Logo

 

Bulletins

Sr.No. Particulars Vol. & No. Months Year
1 Next-generation sequencing- Improves the diagnosis and management of patients with Congenital anemia - Rashmi Dongerdiye and Prabhakar Kedar 51(1) Jan-Apr 2020
2 Autoimmune Lymphoproliferative Syndrome (ALPS) 2 - Priyanka Setia 51(2) May-Aug 2020
3 Serological & molecular techniques for RhD typing and their role in the identification of D variants - Garima Mishra 51 (3) Sep-Dec 2020
4 Fibrinolysis and risk of Venous Thrombosis: An overview- by Aniket Prabhudesai 50 (1) Jan-Apr 2019
5 Spliceosomal Mutations in Myelodysplastic Syndromes and Its Therapeutic Implications- An Overview - Purvi Mohanty 50(2) May-Aug 2019
6 SLIM21: Unique Library Software- Vijay Padwal, Amruta Mahale & Gauri Kesarkar 50 (3) Sep-Dec 2019
7 DARC : Structure, Function and Disease Pathophysiology - Roshan Shaikh 49 (1) Jan - April 2018
8 Protein Glycosylation in Hepatitis B Related Liver Diseases - Kruti Bhavik Dalal 49(2) May - August 2018
9 Chronic Granulamatous Disease- Manasi Kulkarni 49(3) Sep-Dec 2018
10 Adipokines: the new players of inflammatory response in Systemic Lupus Erythematosus - Durga Chougule 48(1) Jan-April 2017
11 Early prediction of preeclampsia using combination of plasma microparticles and serum biomarkers - Anshul Jadli 48 (2) May-Aug 2017
12 Genetic modulators of fetal hemoglobin- Priya Hariharan & Anita Nadkarni 48(3) Sept-Dec 2017
13 Molecular genotyping of blood group antigens 47(1) Jan-April 2016
14 Hepatitis C Infection : Prevalence, Diagnosis and Treatment - An Overview - Priya Yabaji 47(2) May-Aug 2016
15 Fanconi anemia: A multispectrum disease - Avani Solanki 47(3) Sep-Dec 2016
16 The genetic basis of hyperbilirubinemia- Chiddawar A 46(1) Jan-Apr 2015
17 Warfarin pharmacogenetics: Implications for personalized medicine - Tejasvita Gaikwad 46(2) May-Aug 2015
18 Neonatal Sepsis: An Overview - Martin S 46(3) Sep-Dec 2015
19 Imatinib resistant chronic myeloid leukemia and therapeutic approach- Vaidya S 45(1) Jan-Apr 2014
20 Neonatal screening and natural history of sickle cell disease- Upadhye D 45(2) May-Aug 2014
21 Circulating cell-derived procoagulant microparticles in women with unexplained recurrent pregnancy loss- Patil R 45(3) Sep-Dec 2014
22 Cytogenetic and molecular changes in myelodysplastic syndromes- Korgaonkar SA A Novel elisa for diagnosis of Glanzmann's thrombasthenia and the heterozygote carriers- Lobo V 44(1) Jan-Apr 2013
23 Contribution of National Institute of Immunohaematology (NIIH) on Tribal Health Research- Mukherjee MB 44(2) May-Aug 2013
24 Celluler signaling using multi parametric flow cytometry: a learner's guide- Garg S 44(3) Sep-Dec 2013
25 Matrix Metalloproteinases (MMPS)in Human Health and Diseases- Chaudhary AK Rapid Flow Cytometric test using EOSIN-5' – Maleimide dye for the diagnosis of Red Blood Cell membrane disorders- Kedar PS 43(1-2) Jan-Aug 2012
26 Red Cell Membrane Protein Disorders- Warang P A two tube assay for detecting mild to moderate deficiency of Factor XIII- Shanbhag S 43(3) Sep-Dec 2012
27 History of National Institute of Immunohaematology (ICMR)-Ghosh K 42(1-3) Jan-Dec 2011
28 Dr. H.M. Bhatia Oration- Some lessons from the interface of Genetics and Hematology Vol. XXXXI(1) Jan-Apr 2010
29 Rhesus blood group system- structure and function Vol.XXXXI(2) May-Aug 2010
30 Dr. H.M. Bhatia Oration- The Hemoglobinopathies-Thalassemia and Sickle Cell Disease: Paths of Progress- David G. Nathan (President Emeritus, Dana-Farber Cancer Institute, Boston USA. Vol.XXXX(1) Jan-Apr 2009
31 The Use of Hydroxyurea in Sickle Cell Disease Vol. XXXX(2) May-Aug 2009
32 Haemophagocytic Lymphohistiocytosis: Clinical features, pathogenesis and treatment Vol.XXXX(3) Sep-Dec 2009
33 a) Dr. Kanjaksha Ghosh, Institute of Immunohematology (IIH) becomes National Institute of Immunohematology (NIIH) b) Maya Gupta, Manisha Madkaikar, Recent Trends in diagnosis of Paroxysmal nocturnal h XXXIX (1) Jan-Apr 2008
34 Dr. V. Babu Rao, Genetic and Molecular pathology of Fanconi Anemia XXXIX (2) May-Aug 2008
35 Immunogenetics of ANCA associated vasculitis (AAV) review Vol. XXXIX(3) Sept-Dec 2008
36 Coagulation disorders seen through the window of molecular biology XXXVIII (1) Jan-Apr 2007
37 The complexities of the ABO blood group system (past & present) XXXVIII (2) May-Aug 2007
38 Human red cell pyruvate kinase (PK) deficiency XXXVIII (3) Sep-Dec 2007
39 Hereditary hemolytic anemia due to Pyruvate kinase deficiency (The XVIII Dr. H M Bhatia Memorial Oration) XXXVII (1) Jan-April 2006
40 Non invasive prenatal diagnosis – A Review XXXVII (2) May-Aug 2006
41 Arrray comparative genomic hybridization - An efficient tool for genome analysis XXXVII (3) Sept-Dec 2006
42 Strategies for ensuring safe and blood products (The XVII Dr.H M Bhatia memorial oration) XXXVI (1) Jan-April 2005
43 Human platelet specific antigens and neonatal alloimmune thrombocytopenic purpura (NAITP) XXXVI (2) May-Aug 2005
44 Immunodiagnosis of some rheumatic and autoimmune diseases : An overview XXXVI (2) Sept-Dec 2005
45 Current status of understanding biology and management of chronic myeloid leukemia (The XVI Dr.H.M.Bhatia Memorial Oration) XXXV (1) Jan-Apr 2004
46 Concepts of confocal microscopy XXXV (2) May-Aug 2004
47 Fetal hemoglobin levels in adults XXXV (3) Sept-Dec 2004
48 Indian and genetic diversity in the genomic era: implications in health & disease (The XV Dr.H.M.Bhatia Memorial Oration) XXXIII (2) Jan-Apr 2003
49 Molecular genetics of sickle cell disease : an overview XXXIV (2) May-Aug 2003
50 Umbilical cord blood: biology of hematopoietic stem cells and their applications XXXIV (3) Sept-Dec 2003
51 My Experiences from Blood Components to Fractionation at KEM Hospital, Mumbai and SGPGIMS, Lucknow.(The XIV Dr.H.M.Bhatia Memorial Oration) XXXIII (1) Jan-Apr 2002
52 Air Travel & Deep Vein Thrombosis XXXIII (2) May-Aug 2002
53 Diagnostic assays for detection of HIV infection XXXIII (3) Sept-Dec 2002
54 Allogenic bone marrow transplantation : looking back and planning ahead (The XIII Dr.H.M.Bhatia Memorial Oration) XXXII (1) Jan- April 2001
55 ANCA-Anti-Neutrophil Cytoplasmic Antibodies and their role in vasculitis associated kidney disorders XXXII (3) May-Aug 2001
56 Monoclonal antibodies – An overview XXXII (3) Sept-Dec 2001
57 Health Problems of Tribal Population Groups from the State of Maharashtra (The XII Dr.H.M.Bhatia Memorial Oration) XXXI (1) Jan-Apr 2000
58 Resolving problems in pre transfusion investigations in blood group serology XXXI (3) Sept-Dec 2000
59 Progress in Technology for detection of mutations in hematological disorders XXX (1) Jan-April 1999
60 Bone Marrow density study in Patients with Thalassemia Major- A Preliminary Evaluation (The XI Dr.H.M.Bhatia Memorial Oration) XXX (2) May-Aug 1999
61 Hemophilia- From diagnosis to prevention XXX (3) Sept-Dec 1999
62 An overview of the blood programme in India and the need for revamping (The X Dr.H.M.Bhatia Memorial Oration) XXIX (1) Jan-April 1998
63 Donor selection for allogeneic bone marrow transplantation XXIX (2) May-Aug 1998
64 Prevention of Rh alloimmunization and management of Rh (D) haemolytic disease of the newborn by Intrauterine transfusion XXIX (3) Sept-Dec 1998
65 Bone marrow transplantation for thalassemia (The IX Dr.H.M.Bhatia Memorial Oration) XXVIII (1) Jan-June 1997
66 Chromosomal changes in acute leukemia XXVIII (2) July-Dec 1997
67 Pretransplant blood transfusions in renal transplantation—Are They Beneficial? XXVII (1) Jan-Jun 1996
68 Cell Adhesion molecules in Haemopoiesis XXVII (2) Jul-Dec 1996
69 Current concepts in the immunology of allograft rejection XXVI (1) Jan-Apr 1995
70 Megaloblastosis, a morphologic expression of molecular derangementsin DNA and histone biosynthesis (The VI Dr.H.M.Bhatia Memorial Oration) XXVI (2&3) May-Dec 1995
71 Blood transfusion (Red Cell) practices and policy for the Neonate XXV (1) Jan-Apr 1994
72 Apoptosis XXV (2) May-Aug 1994
73 The Haemopoietic progenitor cell XXV (3) Sept-Dec 1994
74 Glucose-6- Phosphate Dehydrogenase deficiency and its variants in India ( The V Dr.H.M.Bhatia Memorial Oration) XXIV (1-3) Jan-Jun 1993
75 The Anti-Idiotype network in systemic lupus erythematosus – A Review XXIV (4) Jul-Sept 1993
76 Recent advances in the management of Rh Hemolytic disease of the newborn (HDN) XXIV (5) Oct-Dec 1993
77 Highlights of the XVIth Annual conference of the Bombay Haematology group (BHG) XXIII (1) Jan-Feb 1992
78 Molecular approaches to the detection of agents in persistent viral infections (The IV Dr.H.M.Bhatia Memorial Oration) XXIII (2) Mar-Apr 1992
79 Quality assurance in blood bank XXIII (3) May-Jun 1992
80 Preventive Hematology XXIII (4) July-Aug 1992
81 Autologus Transfusion XXIII (5) Sep-Oct 1992
82 Hematopoietic growth factors : Colony stimulating factors XXIII (6) Nov-Dec 1992
83 A report on blood banking in India XXII (1) Jan-Mar 1991
84 Erythrocytes G6PD deficiency and its variants in West Bengal (The IIIrd Dr. H. M.Bhatia memorial oration) XXII (2) Apr-Jun 1991
85 Genetic red cell defects and malaria XXII(3-4) July-Dec 1991
86 1)Studies on some aspects of the HLA system 2) HLA studies at the Cancer Research Institute (The Second Dr. H.M.Bhatia Memorial Oration) XXI (1) Jan-Mar 1990
87 Preliminary report of blood component therapy (CT) experience at K.E.M. blood bank XXI (2) Apr- June 1990
88 Monoclonal antibodies in Hematology : Some less known facts XXI (3) July-Sept 1990
89 World congress on AIDS – Some highlights and update XXI (4) Oct-Dec 1990
90 Recent developments in transfusion medicine (The first Dr. H. M. Bhatia Memorial Oration) XX (1) Jan-Feb 1989
91 Community control of β-thalassemia XX (2) Mar-Apr 1989
92 Antibody dependent cell mediated phagocytosis and cytolysis XX (3) May-June 1989
93 The H antigen of the ABO blood group system XX (4) Jul-Aug 1989
94 AIDS and HIV infection: An Epidemiological overview XX (5) Sep-Oct 1989
95 Health education in sickle cell disease XX (6) XX (6) 1989
96 Genetics and epidemiology of Sickle cell anemia in India XIX (1) Jan-Feb 1988
97 Intravenous immunoglobulin (IVIG) therapy – an alternate approach in the treatment of Idiopathic Thrombocytopenic Purpura (ITP) XIX (2) Mar-April 1988
98 The red cell membrane and it's vesiculation XIX (3) May-Jun 1988
99 Structure and genetic aspects of the HLA systems XIX (4) July-Aug 1988
100 Institute of Immunohaematology – referral services XIX (5) Sep-Oct 1988
101 Neonatal thrombocytopenia XIX (6) Nov-Dec 1988
102 Genetic parameters: Biologic and epidemiologic significance XVIII (1) Jan-Feb 1987
103 Application of recombinant DNA technology for gene mapping of immunoglobulins XVIII (2) Mar-Apr 1987
104 C1q the first complement component -A review XVIII (3) May-June 1987
105 Chemistry of FVIII molecule XVIII (4) July-Aug 1987
106 Platelet transfusion and thrombocytopenic haemorrhagic disorders XVII (1) Jan-Feb 1986
107 Hodgkin's disease: historical perspective current status and future directions XVII (2) Mar-Apr 1986
108 Prenatal diagnosis of hemoglobinopathies XVII (3) May-Jun 1986
109 Acquired immune deficiency syndrome,(AIDS) its impact on blood transfusion services XVII (4) Jul – Aug 1986
110 Immunoblotting in Immunohaematology XVII (5) Sept-Oct 1986
111 ELISA Today XVII (6) Nov-Dec 1986
112 Human blood XVI (1) Jan-Feb 1985
113 Preparation and function of platelet components made in glass bottles. XVI (2) Mar-Apr 1985
114 Outline of biochemical changes of blood coagulation and coagulation disorders XVI (3) May-June 1985
115 Red cell serology in blood bank: an excercise in quality control XVI (4) July-Aug 1985
116 Immunofluorescent techniques in immunohaematology XVI (5) Sep-Oct 1985
117 Preservation of red cells in pilot tubes in blood banks. XVI (6) Nov-Dec 1985
118 Distribution of some genetic markers with special reference to Western India. XV (1) Jan-Feb 1984
119 HLA, Biological anthropology and India. XV (2) Mar-Apr 1984
120 Immunohaematological aspects of the complement system. XV (3) May-June 1984
121 Profile of immune response in iron deficiency system. XV (4) July-Aug 1984
122 Impact of the HLA system on immunogenetic research. XV (5) Sep-Oct 1984
123 Recent concepts in management of Rh haemolytic disease of the newborn. XV (6) Nov-Dec 1984
124 Discrepancies in ABO grouping XIV (1) Jan-Feb 1983
125 Data analysis of HBsAg testing workshop XIV (2) Mar-Apr 1983
126 Cell surface marker studies using monoclonal antibodies XIV (3) May-June 1983
127 Atypical blood group antibodies in blood group transfusion practice XIV (4) July-Aug 1983
128 2 nd HLA workshop on serum screening quality control. XV (5) Sept-Oct 1983
129 Application of cell separator machines XV (6) Nov-Dec 1983

 

 

 

Quick links

Home
Contact
Committees
ICMR
DHR
MOHFW
WHO
UNICEF
UNFPA
How to Reach Us
By Air : Nearest airport is Chhatrapati Shivaji International Airport, Mumbai..

By Rail : Nearest railway stations to reach NIIH are Dadar/ Prabhadevi station (Western Railway), Parel (Central Railway) and Sewri (Harbour Railway)..

By Road : Easily accessible through Western and Eastern express highway through Sion and Dadar routes..

Map

2022 © ICMR-National Institute of Immunohaematology, Parel, Mumbai